Skip to main content

Exit WCAG Theme

Switch to Non-ADA Website

Accessibility Options

Select Text Sizes

Select Text Color

Website Accessibility Information Close Options
Close Menu

Author Archives: Site Administrator

Court Grants Partial Summary Judgment on Stark Law Violations but Denies it on False Claims Act Claims in Qui Tam Whistleblower Case Against Halifax Hospital

By Rabin Kammerer Johnson |

A federal judge has granted partial summary judgment on claims alleging Stark Law violations in a qui tam case brought by a whistleblower against Halifax Hospital Medical Center and Halifax Staffing, Inc. The court denied summary judgment as to the amount of the damages caused by the Stark Law violations and denied it as… Read More »

Facebook Twitter LinkedIn

Caremark to Pay $4.25 to Settle Whistleblower Claim Filed Under the Qui Tam Provisions of the False Claims Act

By Rabin Kammerer Johnson |

Caremark LLC, operated by CVS Caremark Corp., has agreed to settle a whistleblower claim filed under the qui tam provisions of the federal False Claims Act. Caremark is one of the largest pharmacy benefit management (“PBM”) companies in the U.S. CVS is one of the largest retail pharmacies in the country. A PBM is… Read More »

Facebook Twitter LinkedIn

Nursing Home Operator Will Pay $48 Million to Settle False Claims Act Allegations in Qui Tam Cases Filed by Whistleblowers

By Rabin Kammerer Johnson |

California-based The Ensign Group, Inc. has agreed to pay $48 million to settle allegations that it violated the False Claims Act. The allegations were made in two separate qui tam lawsuits originally brought by whistleblowers in the United States District Court for the Central District of California. The two whistle blowers, Gloria Patterson and… Read More »

Facebook Twitter LinkedIn

CA Technologies Agrees to Settle Whistleblower Qui Tam Lawsuit

By Rabin Kammerer Johnson |

CA Technologies has agreed to pay $11 million to settle allegations first made by a whistleblower under the qui tam provisions of the False Claims Act. According to CA Technologies’ website, it is an IT management software and solutions company with approximately 14,000 employees that has generated $4.643 billion in revenue in 2013. The… Read More »

Facebook Twitter LinkedIn

U.S. Court of Appeals Dismisses Qui Tam Suit Because of Whistleblower Lawyer’s Breach of Client Confidentiality

By Rabin Kammerer Johnson |

The U.S. Court of Appeals for the Second Circuit has dismissed a qui tam lawsuit against Quest Diagnostics, Inc. and Unilab Corporation. The whistleblower litigation was initiated by three former employees of Unilab, including its former general counsel, Mark Bibi. In Fair Lab. Practices Assocs. v. Quest Diagnostics, Inc., 2013 BL 295703, 2d Cir.,… Read More »

Facebook Twitter LinkedIn

Consumers Energy Co. the Target of $4 Billion Qui Tam Whistleblower Lawsuit

By Rabin Kammerer Johnson |

Michigan-based utility company, Consumers Energy Co. (“CEC”), is the subject of a recently unsealed whistleblower action. A former CEC employee, Simeon Anderson, filed a qui tam lawsuit alleging that CEC committed fraud on its customers, the federal government, and the state of Michigan by more than $4 billion. According to the complaint, CEC created… Read More »

Facebook Twitter LinkedIn

Bank of New York Mellon Settles Florida Qui Tam Whistleblower Suit

By Rabin Kammerer Johnson |

The Florida Attorney General announced that Bank of New York Mellon (“BNY”) has agreed to pay $28 million to settle a Florida False Claims Act suit concerning foreign currency trades executed by BNY on behalf of the Florida Retirement System Trust Fund. The case was one of several lawsuits filed under the qui tam… Read More »

Facebook Twitter LinkedIn

Johnson & Johnson and Subsidiaries Agree to $2.2 Billion Global Settlement of Whistleblower Lawsuit

By Rabin Kammerer Johnson |

The Department of Justice announced that worldwide healthcare company Johnson & Johnson and its subsidiaries, Janssen Pharmaceuticals, Inc. and Scios, Inc., have agreed to settle criminal and civil allegations concerning the promotion of off-label uses for the prescriptions drugs Risperdal, Invega, and Natrecor, and the payment of kickbacks. According to its website, Johnson &… Read More »

Facebook Twitter LinkedIn

Government Intervenes in Qui Tam Whistleblower Lawsuit Alleging Inadequate Background Checks

By Rabin Kammerer Johnson |

The Justice Department announced that the federal government has intervened in a whistleblower lawsuit alleging that United States Investigations Services, LLC (“USIS”), a government contractor, violated the False Claims Act. The lawsuit claims that Virginia-based USIS failed to comply with the provisions of its contract with the U.S. Office of Personnel Management (“OPM”). Since… Read More »

Facebook Twitter LinkedIn

Florida False Claims Act Revised to Conform to Federal Qui Tam Whistleblower Statute

By Rabin Kammerer Johnson |

In 2013, the Florida Legislature amended the Florida False Claims Act (“FFCA”), codified at sections 68.081 et seq., Florida Statutes. The FFCA is modeled after its federal counterpart, the False Claims Act (“FCA”), which was first enacted during the Civil War to combat fraud against the government by defense contractors. The FFCA authorizes private… Read More »

Facebook Twitter LinkedIn

By submitting this form I acknowledge that form submissions via this website do not create an attorney-client relationship, and any information I send is not protected by attorney-client privilege.

Skip footer and go back to main navigation